Liquid Biopsy Enables Quantification of the Abundance and Interindividual Variability of Hepatic Enzymes and Transporters 2020 年 11 月 13 日 Facebook LinkedIn Twitter Facebook LinkedIn Twitter Continue to Article Recommended for you Certara 获得 FDA 批准，进一步推进使用生物模拟的仿制药虚拟生物等效性评估 新闻发布 Essentials of Model-informed Drug Development (MIDD) – Top-down vs. Bottom-up Approaches 博客 British Pharmacology Society:Pharmacology 2021 会议 Using Simcyp Simulator to Determine DDI Liability of Guanfacine in Children 案例研究
